Is hidradenitis suppurativa more an autoinfection than pure autoinflammation?

• by Maïa Delage, Olivier Join-Lambert, Snaigune Miskinyte, Alain Hovnanian, Aude Nassif

• July 6, 2026

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

• by Juling Sia, Bernett Lee, Hazel H. Oon

• April 22, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review

• by Julia Alicja Lewandowska, Agnieszka Owczarczyk–Saczonek

• May 19, 2026